プレスリリース

Elekta Chooses Brainlab as Exclusive Distributor in the U.S. for Stereotactic Neurosurgery Solutions

Dec/13/2017

Contrast Clearance Analysis Software Receives FDA 510(k) Clearance

Dec/05/2017

Leading European ENT Surgeons Share Best-Practices and Technological Advancements at 3rd Brainlab ENT Symposium

Nov/23/2017

Over 1,000 Multiple Brain Metastases Patients Treated with Brainlab Indication-Specific Software

Nov/16/2017

Brainlab Takes Part in MUNICH-PINK Breast Cancer Awareness Campaign

Oct/24/2017

Navigating The Future Of Neuro And Spine Technology

Sep/29/2017

Elekta and Brainlab Collaborate to Streamline Treatment Workflows for Stereotactic Radiation Therapy

Sep/22/2017

Brainlab Announces FDA Clearance for Two New Indication-Specific Radiosurgery Software Applications

Sep/21/2017

Elekta Chooses Brainlab to Distribute Stereotactic Neurosurgical Solutions within Selected Markets in Europe

Jun/26/2017

Seventh International Novalis Circle Conference Further Establishes Best Practices and Promotes Wider Access to Advanced Stereotactic Radiosurgery Treatments

Jun/13/2017

Medicenna’s Immunotherapy Phase 2b Trial Underway Using Brainlab Drug Delivery Technology

Jun/07/2017

Brainlab Chief Financial Officer Joseph Doyle to Retire

May/23/2017

Accelerated Adoption of New Radiosurgery Software from Brainlab

May/04/2017

Brainlab Names New Member of Executive Board

May/02/2017

Brainlab Fosters Advancement and Interdisciplinary Collaboration in Radiosurgery

Apr/13/2017

Digital O.R. – Raising the Bar for Information Integration in the Operating Room

Mar/30/2017

Brainlab Raises Awareness about Radiosurgery for Brain Metastases Patients on World Cancer Day 2017

Feb/03/2017

Brainlab and Elekta Celebrate 50th Installation of ExacTrac with Versa HD

Jan/11/2017

First Japanese Cancer Center to Demonstrate Commitment to Radiotherapy Patient Safety and Treatment Quality with Novalis Certified

Jan/10/2017